16-31185081-TGGCGGCGGCGGCGGC-TGGCGGCGGCGGCGGCGGCGGC
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP3BP6
The NM_004960.4(FUS):c.681_686dupCGGCGG(p.Gly228_Gly229dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000672 in 1,607,566 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. G229G) has been classified as Likely benign.
Frequency
Consequence
NM_004960.4 disruptive_inframe_insertion
Scores
Clinical Significance
Conservation
Publications
- amyotrophic lateral sclerosisInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, Illumina
- amyotrophic lateral sclerosis type 6Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen
- juvenile amyotrophic lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- tremor, hereditary essential, 4Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FUS | NM_004960.4 | c.681_686dupCGGCGG | p.Gly228_Gly229dup | disruptive_inframe_insertion | Exon 6 of 15 | ENST00000254108.12 | NP_004951.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FUS | ENST00000254108.12 | c.681_686dupCGGCGG | p.Gly228_Gly229dup | disruptive_inframe_insertion | Exon 6 of 15 | 1 | NM_004960.4 | ENSP00000254108.8 |
Frequencies
GnomAD3 genomes AF: 0.000119 AC: 18AN: 151526Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000558 AC: 13AN: 232882 AF XY: 0.0000474 show subpopulations
GnomAD4 exome AF: 0.0000618 AC: 90AN: 1455922Hom.: 0 Cov.: 32 AF XY: 0.0000511 AC XY: 37AN XY: 723972 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000119 AC: 18AN: 151644Hom.: 0 Cov.: 32 AF XY: 0.000162 AC XY: 12AN XY: 74094 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Amyotrophic lateral sclerosis type 6;C3539195:Tremor, hereditary essential, 4 Uncertain:1
This variant, c.681_686dup, results in the insertion of 2 amino acid(s) of the FUS protein (p.Gly230_Gly231dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs372671599, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with FUS-related conditions. ClinVar contains an entry for this variant (Variation ID: 649131). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
FUS-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inborn genetic diseases Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at